Dr. Carl W. Hastings
, vice chairman and chief scientific officer of Reliv International, Inc., was elected to the board of directors of the Council for Responsible Nutrition (CRN), the nation's leading trade association for the dietary supplement industry.
Dr. Hastings oversees research, development of nutritional products, quality control and manufacturing for Reliv, a direct selling company of nutritional products. He has created Reliv's core product line and is the holder of five patents for his work, and patents are pending on additional products.
"I share the values of the Council for Responsible Nutrition, particularly its dedication to advancing scientific research of dietary supplements and its commitment to a strong code of ethics," Dr. Hastings said.
Dr. Hastings, 67, joined Reliv as head of research and development shortly after the company was founded. He holds U.S. patents for Innergize!®, FibRestore®, Cellebrate®, Arthaffect® and ReversAge®, and has patents pending on CardioSentials and GlucAffect.
His career spans nearly 40 years in food product research and development, beginning at Mead Johnson & Co. where Dr. Hastings conducted research on nutritional food products for adults and infants, and developed low-calorie foods marketed under the Weight Watchers label.
With the A.E. Staley Company, Dr. Hastings developed new applications for food ingredients from corn and soybeans, including starch, sweeteners, protein and fiber.
Dr. Hastings earned a Ph.D. in food science from the
University of Illinois
, where he also earned his bachelor's and master's degrees.
Reliv International, Inc., based in
, is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women's health and anti-aging. Reliv sells its products through an international network marketing system of approximately 68,000 independent distributors. Additional information about Reliv International, Inc. can be obtained on the Web at